Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2020

01-08-2020 | Thrombocytopenia

Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life

Authors: Azza A. Tantawy, Nayera H. K. Elsherif, Mahmoud A. Kenny, Khaled A. Aboulfotouh, Ahmed E. Hassan, Marwa E. Kabil

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2020

Login to get access

Abstract

Occult hemorrhage can occur in any internal organ in ITP patients. Four sites of occult hemorrhage require attention including microscopic hematuria, fecal occult blood loss, retinal hemorrhage, and silent intracranial hemorrhage. The aim of this study was to investigate the frequency of subclinical bleeding in children with ITP and its relation to clinical and laboratory disease parameters including bleeding score and health related quality of life. This cross-sectional study included 40 ITP patients recruited from the Pediatric Hematology/Oncology unit, Children’s Hospital, Ain Shams University, Cairo, Egypt. Inclusion criteria were patients with ITP (acute, persistent or chronic) having platelet count of 20,000/cmm or less at diagnosis/relapse, patients with overt bleeding and patients with secondary ITP were excluded. Occult blood in stools and urine analysis, fundus examination, and non-contrast brain MRI for microbleeds were done. Out of the forty included patients, 24 had chronic, 11 had acute and 5 had persistent ITP. Eleven patients had occult bleeds. Two patients had occult blood in stools, five had microscopic hematuria, one had retinal bleeds and three patients had brain microbleeds. Their mean age was 10.23 ± 4.18 years and their mean initial bleeding score was 2.55 ± 0.82. Nine patients with occult bleeding were chronic, one persistent and one acute ITP patients. There were no significant differences between patients with occult bleeding and those without as regards the initial bleeding score, platelet counts and hemoglobin level, as well as the mean platelet counts and mean hemoglobin level over the disease duration (p > 0.5). The scoring of the parent’s life, Child and parents’ quality of life was low in 3 out of 11 patients with occult bleeding. There was no significant difference between patients with occult bleeding and those without as regards the ITP child and parents’ quality of life items (p = 0.850 and 0.511 respectively). Our results suggest that subclinical bleeding is a potential risk in children with ITP, more commonly chronic ITP patients. We could not demonstrate a significant relation of occult bleeding to the laboratory findings, bleeding score, and the ITP health quality of life; nevertheless, the significance of the routine assessment of occult bleeding in ITP and the identification of high-risk patients require additional studies.
Literature
1.
go back to reference Grainger JD, Locatelli F, Chotsampanchargen T, Donyush E, Ponotanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Ivengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK (2015) Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet 386:1649–1658CrossRef Grainger JD, Locatelli F, Chotsampanchargen T, Donyush E, Ponotanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Ivengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK (2015) Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet 386:1649–1658CrossRef
2.
go back to reference Sabhan A, Al Jadiry M, Ghali H, Abed W, AlHadad S (2016) Chronic immune thrombocytopenic purpura in children overview of 60 patients. Pediatr Hematol Oncol J 1(1):9–12CrossRef Sabhan A, Al Jadiry M, Ghali H, Abed W, AlHadad S (2016) Chronic immune thrombocytopenic purpura in children overview of 60 patients. Pediatr Hematol Oncol J 1(1):9–12CrossRef
3.
go back to reference Arnold D (2015) Bleeding complications in immune thrombocytopenia. Hematology 15(1):237–242CrossRef Arnold D (2015) Bleeding complications in immune thrombocytopenia. Hematology 15(1):237–242CrossRef
4.
go back to reference Flores A (2013) Occult hemorrhage in immune thrombocytopenia. Semin Hematol 50(1):26–30CrossRef Flores A (2013) Occult hemorrhage in immune thrombocytopenia. Semin Hematol 50(1):26–30CrossRef
5.
go back to reference Kuhne T (2018) Advances in chemical pharmacotherapy for the treatment of pediatric immune thrombocytopenia. Exp Opin Pharmacother 19(7):667–676CrossRef Kuhne T (2018) Advances in chemical pharmacotherapy for the treatment of pediatric immune thrombocytopenia. Exp Opin Pharmacother 19(7):667–676CrossRef
6.
go back to reference Flores A, Buchanan G (2015) Occult hemorrhage in children with severe ITP. Am J Hematol 91(3):287–290CrossRef Flores A, Buchanan G (2015) Occult hemorrhage in children with severe ITP. Am J Hematol 91(3):287–290CrossRef
7.
go back to reference Matoth Y, Zaizov R, Frankel JJ (1971) Minimal cerebral dysfunction in children with chronic thrombocytopenia. Pediatrics 47:698–706PubMed Matoth Y, Zaizov R, Frankel JJ (1971) Minimal cerebral dysfunction in children with chronic thrombocytopenia. Pediatrics 47:698–706PubMed
8.
go back to reference Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB (2009) Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 114:4777–4783CrossRef Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB (2009) Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 114:4777–4783CrossRef
9.
go back to reference Rhodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel J, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kuhne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R (2013) Standardization of bleeding assessment in immune thrombocytopenia: Report from the international working group. Blood 121(14):2596–2606CrossRef Rhodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel J, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kuhne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R (2013) Standardization of bleeding assessment in immune thrombocytopenia: Report from the international working group. Blood 121(14):2596–2606CrossRef
10.
go back to reference Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AKC, Young NL (2007) Validity, reliability and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the kids ITP tools. J Pediatr 37(1):510–515CrossRef Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AKC, Young NL (2007) Validity, reliability and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the kids ITP tools. J Pediatr 37(1):510–515CrossRef
11.
go back to reference Diven SC, Travis LB (2000) A practical primary care approach to hematuria in children. Pediatr Nephrol 14:65CrossRef Diven SC, Travis LB (2000) A practical primary care approach to hematuria in children. Pediatr Nephrol 14:65CrossRef
12.
go back to reference Charidimou A, Kakar P, Fox Z, Werring D (2013) Cerebral microbleeds and recurrent stroke risk. Stroke 44(4):995–1001CrossRef Charidimou A, Kakar P, Fox Z, Werring D (2013) Cerebral microbleeds and recurrent stroke risk. Stroke 44(4):995–1001CrossRef
13.
go back to reference Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI; NOPHO ITP Working Group (2003) Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 143(3):302–307CrossRef Rosthøj S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter JI; NOPHO ITP Working Group (2003) Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 143(3):302–307CrossRef
14.
go back to reference Fleiss JL, Levin B, Paik MC (2003) Statistical methods for rates and proportions, 3rd edn. Wiley, New YorkCrossRef Fleiss JL, Levin B, Paik MC (2003) Statistical methods for rates and proportions, 3rd edn. Wiley, New YorkCrossRef
15.
go back to reference Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazy I, Kelton JG, Arnold DM (2016) Severe bleeding events in adults and children with primary immune thrombocytopenia A systematic review. J Thromb Hemost 13(3):457–464CrossRef Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazy I, Kelton JG, Arnold DM (2016) Severe bleeding events in adults and children with primary immune thrombocytopenia A systematic review. J Thromb Hemost 13(3):457–464CrossRef
16.
go back to reference Bolton-Maggs PH, Elalfy M (2013) Commentary on session: immune thrombocytopenia nomenclature, guidelines and natural history. Semin Hematol 50:510–511CrossRef Bolton-Maggs PH, Elalfy M (2013) Commentary on session: immune thrombocytopenia nomenclature, guidelines and natural history. Semin Hematol 50:510–511CrossRef
17.
go back to reference Dang S, Atiq M, Julka R, Olden KW, Aduli F (2009) Isolated gastric mucosal hemorrhages in idiopathic thrombocytopenic purpura. Gastrointest Endosc 70:167CrossRef Dang S, Atiq M, Julka R, Olden KW, Aduli F (2009) Isolated gastric mucosal hemorrhages in idiopathic thrombocytopenic purpura. Gastrointest Endosc 70:167CrossRef
18.
go back to reference Shah PA, Yang SS, Fung WE (2005) Idiopathic thrombocytopenic purpura with massive subretinal hemorrhage. Arch Ophthalmol 123(11):1612–1613CrossRef Shah PA, Yang SS, Fung WE (2005) Idiopathic thrombocytopenic purpura with massive subretinal hemorrhage. Arch Ophthalmol 123(11):1612–1613CrossRef
19.
go back to reference Goel N, Arora S, Jain P, Ghosh B (2013) Massive subretinal and vitreous hemorrhages at presentation in idiopathic thrombocytopenic purpura: report of a case and review literature. Clin Exp Optom 97(3):270–273CrossRef Goel N, Arora S, Jain P, Ghosh B (2013) Massive subretinal and vitreous hemorrhages at presentation in idiopathic thrombocytopenic purpura: report of a case and review literature. Clin Exp Optom 97(3):270–273CrossRef
20.
go back to reference Capua T, Cohen N, Anafy A, Greisman D, Levin D, Rimon A (2019) Routine fundoscopy in immune thrombocytopenic purpura-is it really necessary? Eur J Pediatr 178(6):957–960CrossRef Capua T, Cohen N, Anafy A, Greisman D, Levin D, Rimon A (2019) Routine fundoscopy in immune thrombocytopenic purpura-is it really necessary? Eur J Pediatr 178(6):957–960CrossRef
21.
go back to reference Kahraman C, Emre H, Gulcan E, Bilen Y, Uludag K, Uyanik A, Keles M (2014) Combined immune thrombocytopenic purpura and immunoglobulin A nephropathy: a similar pathophysiologic process? Ren Fail 36(3):464–465CrossRef Kahraman C, Emre H, Gulcan E, Bilen Y, Uludag K, Uyanik A, Keles M (2014) Combined immune thrombocytopenic purpura and immunoglobulin A nephropathy: a similar pathophysiologic process? Ren Fail 36(3):464–465CrossRef
22.
go back to reference Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG (2017) Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP registry. Blood 1(25):2414–2420 Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG (2017) Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP registry. Blood 1(25):2414–2420
23.
go back to reference Cordonnier C (2011) Brain microbleeds more evidence, but still a clinical dilemma. Curr Opin Neurol 24(1):69–74CrossRef Cordonnier C (2011) Brain microbleeds more evidence, but still a clinical dilemma. Curr Opin Neurol 24(1):69–74CrossRef
24.
go back to reference Kayal L, Jayachandran S, Singh K (2014) Idiopathic thrombocytopenic purpura. Contemp Clin Dent 5(3):410–414CrossRef Kayal L, Jayachandran S, Singh K (2014) Idiopathic thrombocytopenic purpura. Contemp Clin Dent 5(3):410–414CrossRef
25.
go back to reference Buchanan GR, Adix L (2002) Grading of hemorrhage in children with immune thrombocytopenic purpura. J Pediatr 14(5):683–688CrossRef Buchanan GR, Adix L (2002) Grading of hemorrhage in children with immune thrombocytopenic purpura. J Pediatr 14(5):683–688CrossRef
26.
go back to reference Page LK, Psaila B, Provan D, Michael HJ, Jokins JM, Elish AS, Lesser ML, Bussel JB (2007) The immune thrombocytopenia (ITP) bleeding score: assessment of bleeding in patients with ITP. Hematologica 138(2):245–248 Page LK, Psaila B, Provan D, Michael HJ, Jokins JM, Elish AS, Lesser ML, Bussel JB (2007) The immune thrombocytopenia (ITP) bleeding score: assessment of bleeding in patients with ITP. Hematologica 138(2):245–248
27.
go back to reference Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B (2005) Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Hematologica 90(6):829–832 Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B (2005) Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Hematologica 90(6):829–832
28.
go back to reference Pansy J, Minkov M, Dengy R, Quehenberger F, Lackner H, Nebl A, Sovinz P, Schwinger W, Urban C, Benesch M (2010) Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study. Kin Pediatr 222:374–377 Pansy J, Minkov M, Dengy R, Quehenberger F, Lackner H, Nebl A, Sovinz P, Schwinger W, Urban C, Benesch M (2010) Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study. Kin Pediatr 222:374–377
29.
go back to reference Zilber R, Bortz A, Yocobovich J, Yaniv I, Tamary H (2012) Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the Kids ITP tools. J Pediatr Hematol Oncol 34(1):2–5CrossRef Zilber R, Bortz A, Yocobovich J, Yaniv I, Tamary H (2012) Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the Kids ITP tools. J Pediatr Hematol Oncol 34(1):2–5CrossRef
30.
go back to reference Dazord A, Manificat S, Escoffier C, Kadour JL, Bobes J, Gonzales MP, Nicolas J, Cochat P (2000) Quality of life of children: importance of its evaluation. Comparison of children in good health with those at risk (psychological, social, somatic). L’Encephale 26(5), 46–55.PubMed Dazord A, Manificat S, Escoffier C, Kadour JL, Bobes J, Gonzales MP, Nicolas J, Cochat P (2000) Quality of life of children: importance of its evaluation. Comparison of children in good health with those at risk (psychological, social, somatic). L’Encephale 26(5), 46–55.PubMed
31.
go back to reference Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol. 36(3):194–199CrossRef Mokhtar GM, Farid SM, Shaker NM, Farrag KE (2014) Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol. 36(3):194–199CrossRef
32.
go back to reference Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ (2009) Relationships among bleeding severity, health-related quality of life and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53(4):652–654CrossRef Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ (2009) Relationships among bleeding severity, health-related quality of life and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer 53(4):652–654CrossRef
33.
go back to reference Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J (2008) Health-related quality of life of immune thrombocytopenic purpura patients: Results from a web-based survey. Curr Med Res Opin 24(10):2767–2776CrossRef Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J (2008) Health-related quality of life of immune thrombocytopenic purpura patients: Results from a web-based survey. Curr Med Res Opin 24(10):2767–2776CrossRef
34.
go back to reference Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet count. Arch Intern Med 160(11):1630–1638CrossRef Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet count. Arch Intern Med 160(11):1630–1638CrossRef
Metadata
Title
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life
Authors
Azza A. Tantawy
Nayera H. K. Elsherif
Mahmoud A. Kenny
Khaled A. Aboulfotouh
Ahmed E. Hassan
Marwa E. Kabil
Publication date
01-08-2020
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02036-4

Other articles of this Issue 2/2020

Journal of Thrombosis and Thrombolysis 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.